Direct effect of GLP-1 infusion on endogenous glucose production in humans (Q46833674)

25 December 2017

title

Direct effect of GLP-1 infusion on endogenous glucose production in humans (English)

1 reference

25 December 2017

author

Amalia Gastaldelli

3

1 reference

25 December 2017

Brenno D Astiarraga

4

1 reference

25 December 2017

Marta Seghieri

object named as

M Seghieri

1

0 references

Elza Muscelli

object named as

E Muscelli

9

0 references

Eleuterio Ferrannini

10

object named as

E Ferrannini

1 reference

25 December 2017

author name string

E Rebelos

2

1 reference

25 December 2017

A Casolaro

5

1 reference

25 December 2017

E Barsotti

6

1 reference

25 December 2017

A Pocai

7

1 reference

25 December 2017

M Nauck

8

1 reference

25 December 2017

publication date

12 October 2012

1 reference

25 December 2017

published in

Diabetologia

1 reference

25 December 2017

volume

56

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

156-161

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-012-2738-3

exact match

0 references

cites work

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

The theoretical bases of indirect calorimetry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2738-3

Assessment of methods for improving tracer estimation of non-steady-state rate of appearance.

21 January 2018

1 reference

12 December 2020

Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels

1 reference

12 December 2020

Measurement of size and turnover rate of body glucose pool by the isotope dilution method

1 reference

12 December 2020

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

1 reference

12 December 2020

Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects

1 reference

12 December 2020

Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo

1 reference

12 December 2020

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state

1 reference

12 December 2020

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

1 reference

12 December 2020

The Effect of Glucagon-Like Peptide I (GLP-I) on Glucose Elimination in Healthy Subjects Depends on the Pancreatic Glucoregulatory Hormones

1 reference

12 December 2020

Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men

1 reference

12 December 2020

Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1

1 reference

12 December 2020

10.1007/S00125-012-2738-3

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017